Glenmark Life Sciences Limited IPO Date,GMP, Review, Price, Form & Market Lot Details

Glenmark Life Sciences Limited IPO is going to hit the market on 27 July 2021 and closes on 29 July 2021. The company to raise ₹1513.60 crores (approx) via initial public offer with a face value of ₹2 per equity share.


Glenmark Life Sciences Limited IPO is going to hit the market in July 2021 and closes on  July 2021. Glenmark Life Sciences Limited IPO open on Wednesday fixed a price band of Rs. a share for its Rs 1500 crore (approx) IPO. The face value of equity shares is ₹2. Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies. Check out Glenmark Life Sciences Limited IPO details.

How to apply Share Holder Quota in Glenmark Life Sciences Limited IPO:

If you want to apply Glenmark Life Sciences IPO in the share holder quota, you should buy at least 1 share of Glenmark Pharma. It should be in your demat account when the company announce their IPO date or before RHP.

    Glenmark Life Sciences Limited IPO

    Glenmark Life Sciences Limited IPO Date & Price Band:

    IPO Opening Date Jul 27, 2021
    IPO Closing Date Jul 29, 2021
    Issue Type Book Built Issue IPO
    Face Value ₹2 per equity share
    IPO Price ₹695 to ₹720 per equity share
    Market Lot 20 Shares
    Min Order Quantity 20 Share
    Listing At BSE, NSE
    Issue Size [.] Eq Shares of ₹2
    (aggregating up to ₹1513.60 Cr)
    Offer for Sale [.] Eq Shares of ₹2
    (aggregating up to ₹453.60 Cr)

    Glenmark Life Sciences Limited IPO Tentative Timetable

    The Glenmark Life Sciences Limited IPO open date is  27 Jul 2021 , and the close date is 29 Jul 2021. The issue may list on . 
    IPO Open Date Jul 27, 2021
    IPO Close Date Jul 29, 2021
    Basis of Allotment Date Aug 3, 2021
    Initiation of Refunds Aug 4, 2021
    Credit of Shares to Demat Account Aug 5, 2021
    IPO Listing Date Aug 6, 2021

    Glenmark Life Sciences Limited IPO Market Lot:

    The Glenmark Life Sciences Limited IPO minimum market lot is 17 shares with ₹14,229 application amount. The retail investors can apply up-to 14 lots with 238 shares or ₹1,99,206 amount.

    Minimum Lot Size: Minimum 20 Shares
    Minimum Amount: ₹14,400
    Maximum Lot Size: Maximum 260 Shares
    Maximum Amount: ₹187,200

    Glenmark Life Sciences Limited Company Financial:

    Particulars For the year/period ended (₹ in million)
    31-Dec-20 31-Mar-20 31-Mar-19
    Total Assets 19,565.70 17,256.04 14,753.95
    Total Revenue 14,184.72 15,493.03 8,868.65
    Profit After Tax 2,468.97 3,130.98 1,955.92
    Read Also:- 

    Glenmark Life Sciences Limited IPO Form:

    How to apply the Glenmark Life Sciences Limited IPO? You can apply Glenmark Life Sciences Limited IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Clean Science and Technology IPO in the Invest section. The other option you can apply Glenmark Life Sciences Limited IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences Limited IPO forms – click NSE Forms & BSE Forms blank  IPO forms download, fill and submit in your bank or with your broker.

    About Glenmark Life Sciences Limited

    Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
    Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.

    Glenmark Life Sciences Limited IPO Prospectus

       

    Glenmark Life Sciences Limited Company Promoters:

    • Glenmark Pharmaceuticals Limited

    Glenmark Life Sciences Limited IPO Registrar:

    KFin Technologies Private Limited (Formerly known as
    Karvy Fintech Private Limited)

    Selenium Tower-B
    Plot No-31 and 32, Financial District
    Nanakramguda, Serilingampally
    Hyderabad, Rangareddi 500032
    Telangana, India
    Tel: +91 40 6716 2222
    E-mail: glenmark.ipo@kfintech.com
    Investor Grievance E-mail: einward.ris@kfintech.com
    Website: www.kfintech.com
    Contact Person: M Murali Krishna
    SEBI Registration No.: INR000000221

    Glenmark Life Sciences Limited IPO Lead Managers: 

    • Kotak Mahindra Capital Company Limited
    • BofA Securities India Limited
    • Goldman Sachs (India) Securities Private Limited
    • DAM Capital Advisors Limited
    • BOB Capital Markets Limited
    • SBI Capital Markets Limited

    Glenmark Life Sciences Limited Company Address: 

    Glenmark Life Sciences Limited
    Registered Office:
    Plot No. 170-172, Chandramouli Industrial Estate,
    Mohol Bazarpeth, Solapur 413 213, Maharashtra
    Corporate Office:
    Glenmark House, B. D. Sawant Marg,
    Andheri (East), Mumbai 400099,
    Maharashtra, India
    Tel: +912189 234456/ +912189 234246
    Website: www.glenmarklifesciences.com
    Contact Person: Rudalf Corriea
    (Company Secretary and Compliance Officer)
    E-mail: complianceofficer@glenmarklifesciences.com

    Glenmark Life Sciences Limited IPO FAQs

    What is Glenmark Life Sciences Limited IPO?

    Glenmark Life Sciences Limited IPO is a main-board IPO. They are going to raise ₹1513.60 Crores via IPO. The issue is priced at ₹695 to ₹720 per equity share. The IPO to be listed on BSE & NSE.


    When Glenmark Life Sciences Limited IPO will open?

    The Glenmark Life Sciences Limited IPO is to open on 27 July 2021 for QIB, NII, and Retail Investors.


    What is Glenmark Life Sciences Limited IPO Investors Portion?

    The investors’ portion for Glenmark Life Sciences Limited ipo is QIB 50%NII 15%, and Retail 35%.


    How to Apply the Glenmark Life Sciences Limited IPO?

    You can apply Glenmark Life Sciences Limited IPO via ASBA online via your bank account. You can also apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.


    How to Apply the Glenmark Life Sciences Limited IPO through Zerodha?

    Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Glenmark Life Sciences Limited”. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.


    What is Glenmark Life Sciences Limited IPO Size?

    Glenmark Life Sciences Limited IPO size is ₹1513.60 crores (Approx).

    What is Glenmark Life Sciences Limited IPO Price Band?

    Glenmark Life Sciences Limited IPO Price Band is ₹695 to ₹720.

    What is Glenmark Life Sciences Limited IPO Minimum and Maximum Lot Size?

    The minimum bid is 20 Shares with ₹14,400 amount while maximum bid is 260 shares with ₹187,200.

    What is Glenmark Life Sciences Limited IPO Allotment Date?

    Glenmark Life Sciences Limited IPO allotment date is  03 Aug 2021.

    What is Glenmark Life Sciences Limited IPO Listing Date?

    Glenmark Life Sciences Limited IPO listing date is  06 Aug 2021. The IPO to list on BSE and NSE. 

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: